Added to Statin, New Drug Cuts LDL More

A new, injectable drug appears to safely reduce LDL cholesterol, even in people already taking statins, researchers report. The new study was an early test for a type of drug known as a monoclonal antibody. It has to enter the bloodstream through an injection or an intravenous (IV) infusion. The new drug, called REGN727, interferes with an enzyme that keeps the liver from removing LDL from the bloodstream. The study had two parts. The first part, using 72 healthy volunteers, found no safety problems. The second part included 51 people who took a statin but still had high LDL cholesterol. Of these, 21 people had an inherited form and 30 had the usual form. Another 10 people had high LDL but were trying to lower it with diet and exercise only. Everyone received 3 injections within 6 weeks. They received either REGN727 or a placebo.

Content restricted. Requires subscription

Can Aspirin Counteract Cancer?

Taking a daily low dose of aspirin for several years may reduce cancer risk. It also may slow the growth of cancer and reduce the risk of dying from the disease. The results came from three British studies. Two of them analyzed the data from 51 clinical trials. The clinical trials were testing whether aspirin helped to prevent heart attack and stroke. People were randomly assigned to take aspirin or a placebo (fake pill). One of the British studies found that those who took aspirin for at least 5 years had a 37% drop in the risk of dying from cancer. Another showed that people taking aspirin who were later diagnosed with cancer had a lower risk of the cancer spreading to distant sites. They also had half the risk of dying from cancer, compared with people who did not take aspirin.

Content restricted. Requires subscription